Physician profile
Peter N Rigas
NPI 1871715011
$752.00
in general payments reported to CMS, 2019-2025
10 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $25.03 · 2021: $28.94 · 2023: $137 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $255.42 | 2023-2025 | Trumatch, Matrixmandible |
| Medtronic, INC. | $194.52 | 2025 | Propel |
| Stryker Corporation | $188.05 | 2019 | |
| Integra Lifesciences Corporation | $29.02 | 2019-2020 | |
| Hospira, INC. | $17.49 | 2019 | |
| Genzyme Corporation | $15.98 | 2021 | |
| Optinose US, INC. | $13.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.24 | 2019 | |
| Glaxosmithkline, LLC. | $12.96 | 2021 | |
| Ethicon US, LLC | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rigas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.